Lotus Health Secures $35M, OpenAI Ventures into Drug Discovery, and Novartis Builds AI Research Center

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements and investments in the healthcare and life sciences AI sector. This week, Lotus Health has successfully raised $35 million to expand its AI-driven primary care services, ensuring human oversight from board-certified doctors. Meanwhile, the founders of Fitbit have launched Luffu, a new AI platform designed to assist families in monitoring their health, initially through an app with plans for future hardware integration.

In other news, OpenAI CEO Sam Altman has expressed interest in investing in AI drug discovery companies, potentially offering cost subsidies and royalties. Additionally, HealthTrackRx has partnered with SYNERGEN Health to enhance revenue cycle management using AI technology. These stories, along with many others, highlight the ongoing integration of AI in healthcare, aiming to improve efficiency, diagnostics, and patient care across the industry.

Lotus Health Secures $35M for AI Primary Care

Lotus Health has raised $35 million in a Series A funding round to expand its AI-driven primary care services. The company aims to improve healthcare efficiency in the U.S. with its free AI doctor, supported by human oversight. Read more

Fitbit Founders Launch Luffu AI for Family Health Monitoring

The founders of Fitbit, James Park and Eric Friedman, have introduced a new AI startup called Luffu to assist families in monitoring their health. The platform will initially feature an app and plans to incorporate hardware for tracking health data and appointments. Read more

OpenAI May Invest in AI Drug Discovery Firms

At a recent AI conference, OpenAI CEO Sam Altman mentioned the potential for the company to invest in firms using its AI for drug discovery, with possible subsidies and royalties from successful outcomes. Read more

HealthTrackRx Partners with SYNERGEN Health for AI Revenue Management

HealthTrackRx has partnered with SYNERGEN Health to enhance its revenue cycle management using AI-driven technology, aiming to improve operational efficiency and financial performance. Read more

Linda AI Raises €2.6M for Dental Voice AI

Linda AI has secured €2.6 million in funding to enhance its voice AI platform for dental practices in Ireland and the UK, focusing on automating front-desk operations. Read more

Optum Introduces AI Tools for Healthcare Efficiency

Optum has launched AI-powered digital tools to streamline prior authorization in healthcare, aiming to reduce delays and administrative burdens. Read more

Alaffia Health Raises $55M to Enhance AI Platform

Alaffia Health has secured $55 million in Series B funding to improve its AI platform, which aims to reduce waste in health plan claims. The funding will aid in product development and team expansion. Read more

Alabama Lawmakers Introduce AI Regulation Bills

Lawmakers in Alabama have proposed new bills to regulate AI, focusing on health care oversight, content disclosure, and age verification for AI chatbots. Read more

Phylo Inc. Raises $13.5M for AI Biomedical Tool

Phylo Inc. has secured $13.5 million in seed funding to enhance its AI-driven biomedical research tool, Biomni Lab, which is already used by over 4,300 organizations. Read more

AI System Predicts Substance Use Disorder Behaviors

A study by the University of Cincinnati has developed an AI system that predicts substance use disorder behaviors with 83% accuracy, aiming to aid clinicians in diagnosis and treatment. Read more

Ginkgo Bioworks and OpenAI Cut Protein Synthesis Costs with GPT-5

A collaboration between Ginkgo Bioworks and OpenAI has led to a 40% reduction in the costs of cell-free protein synthesis using GPT-5. The autonomous lab achieved a new cost benchmark for producing superfolder green fluorescent protein. Read more

Brainomix Unveils AI Stroke Platform at Conference

At the International Stroke Conference, Brainomix launched its Brainomix 360 Stroke Next Generation platform, which includes a new net water uptake feature for enhanced stroke detection using CT scans. Read more

Novartis Begins Construction on AI-Enhanced Research Center

Novartis has started building a new Biomedical Research center in San Diego, focusing on drug discovery with advanced AI technologies. The facility is part of a larger investment in U.S. R&D and manufacturing. Read more

DermaGPT's New Framework for Dermatology Diagnostics

DermaGPT has launched a federated multimodal framework aimed at enhancing dermatology diagnostics with a focus on privacy and interpretability. The system combines vision-language and large language models to ensure accurate and secure diagnostic processes. Read more

beHuman Raises $4M for AI Cancer Screening

beHuman, a preventive care platform, has secured $4 million in seed funding to enhance AI-driven cancer screening for underserved populations. The funding will support the use of 'Agentic AI' to automate tasks and improve early detection. Read more

Deep Learning Model PARM Developed for Cancer Diagnostics

Researchers at the Netherlands Cancer Institute and Oncode Institute have developed a deep learning model called PARM to predict the impact of regulatory mutations on gene activity, potentially advancing cancer diagnostics. Read more

NCH Uses AI to Boost Polyp Detection in Colonoscopies

NCH has implemented the GI Genius™ AI system to enhance colonoscopy procedures by improving polyp and abnormality detection rates by nearly 14%. This initiative is part of NCH's efforts to advance early cancer prevention through technology. Read more

GE HealthCare and Diagnoly Collaborate on AI for Ultrasound

GE HealthCare has partnered with Diagnoly to integrate AI technology into its ultrasound systems, aiming to improve fetal examination accuracy. Read more

Generate Biomedicines Files for IPO After Major Funding

Generate Biomedicines, an AI-driven biotech company, has filed for an IPO following significant funding from stock sales and collaborations with Novartis and Amgen. The company is progressing its lead therapy for severe asthma into Phase 3 trials. Read more

Mass General Brigham's AI Tool Predicts Brain Health

Researchers at Mass General Brigham have developed an AI model called BrainIAC to predict brain age, assess dementia risk, and estimate cancer survival using brain MRIs. Read more

Garner Health Secures $118M to Boost AI Healthcare Solutions

Garner Health has raised $118 million in Series D funding to enhance its AI-driven provider-ranking engine and incentive platform, aiming to improve healthcare quality and reduce costs. Read more

Exxat Gains Investment from Accel-KKR for AI in Healthcare Education

Exxat has received a minority growth investment from Accel-KKR to boost AI-driven product innovation in healthcare education. This strategic partnership aims to expand Exxat's influence in supporting academic programs and learners. Read more

Stellaromics Appoints New Board Members

Stellaromics has appointed Stacie Weninger, PhD, and Steve McPhail to its Board of Directors to support growth in 3D spatial multi-omics and expand Pyxa™ technology. Read more

Categories

Companies

Resources

Lotus Health Secures $35M, OpenAI Ventures into Drug Discovery, and Novartis Builds AI Research Center - Life AI Weekly #54

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly